ATE381931T1 - Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus - Google Patents

Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus

Info

Publication number
ATE381931T1
ATE381931T1 AT05789989T AT05789989T ATE381931T1 AT E381931 T1 ATE381931 T1 AT E381931T1 AT 05789989 T AT05789989 T AT 05789989T AT 05789989 T AT05789989 T AT 05789989T AT E381931 T1 ATE381931 T1 AT E381931T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
bradykinin antagonists
peptidic bradykinin
peptidic
antagonists
Prior art date
Application number
AT05789989T
Other languages
English (en)
Inventor
Patrizia Felicetti
Christopher Fincham
Alessandro Giolitti
Carlo Maggi
Laura Quartara
Cristina Rossi
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Application granted granted Critical
Publication of ATE381931T1 publication Critical patent/ATE381931T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05789989T 2004-10-15 2005-09-27 Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus ATE381931T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001963A ITMI20041963A1 (it) 2004-10-15 2004-10-15 "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"

Publications (1)

Publication Number Publication Date
ATE381931T1 true ATE381931T1 (de) 2008-01-15

Family

ID=35810869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05789989T ATE381931T1 (de) 2004-10-15 2005-09-27 Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus

Country Status (29)

Country Link
US (1) US7645759B2 (de)
EP (1) EP1799214B8 (de)
JP (1) JP4980917B2 (de)
CN (1) CN101039671B (de)
AR (1) AR051392A1 (de)
AT (1) ATE381931T1 (de)
AU (1) AU2005293881B2 (de)
BR (1) BRPI0515983A (de)
CA (1) CA2583920C (de)
CY (1) CY1107254T1 (de)
DE (1) DE602005004039T2 (de)
DK (1) DK1799214T3 (de)
EA (1) EA010913B1 (de)
ES (1) ES2299090T3 (de)
GE (1) GEP20115322B (de)
HR (1) HRP20080107T3 (de)
IL (1) IL182494A (de)
IT (1) ITMI20041963A1 (de)
MA (1) MA29007B1 (de)
MX (1) MX2007004297A (de)
NO (1) NO339805B1 (de)
NZ (1) NZ554469A (de)
PL (1) PL1799214T3 (de)
PT (1) PT1799214E (de)
RS (1) RS50563B (de)
SI (1) SI1799214T1 (de)
UA (1) UA86091C2 (de)
WO (1) WO2006040004A1 (de)
ZA (1) ZA200703009B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP2086935A1 (de) 2006-10-16 2009-08-12 Grünenthal GmbH Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
ITMI20072225A1 (it) * 2007-11-23 2009-05-24 Luso Farmaco Inst "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso"
IT1391236B1 (it) 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
WO2015155323A1 (en) * 2014-04-10 2015-10-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Br2 antagonist for use in the prevention of the hypotensive effect of patient treated with angiotensin-converting enzyme inhibitors (acei)
IL314752A (en) * 2016-09-16 2024-10-01 Takeda Pharmaceuticals Co Metabolite biomarkers for diseases associated with the contact activation system
SMT202200154T1 (it) 2017-11-24 2022-05-12 Pharvaris Netherlands B V Nuovi antagonisti del recettore della bradichinina b2
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) * 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
HRP20260166T1 (hr) 2022-03-25 2026-03-27 Pharvaris Gmbh Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (de) * 2005-07-05 2007-01-10 Jerini AG Antagonisten von Kinin zur Behandlung von Blasenfunktionsstoerungen

Also Published As

Publication number Publication date
PL1799214T3 (pl) 2008-05-30
PT1799214E (pt) 2008-03-31
HRP20080107T3 (en) 2008-05-31
MA29007B1 (fr) 2007-11-01
DK1799214T3 (da) 2008-05-13
EP1799214A1 (de) 2007-06-27
UA86091C2 (ru) 2009-03-25
DE602005004039D1 (de) 2008-02-07
CA2583920C (en) 2013-02-12
GEP20115322B (en) 2011-11-10
AR051392A1 (es) 2007-01-10
EP1799214B8 (de) 2008-06-18
DE602005004039T2 (de) 2009-01-22
EA010913B1 (ru) 2008-12-30
NO20071840L (no) 2007-04-11
CY1107254T1 (el) 2012-11-21
NO339805B1 (no) 2017-02-06
US20070281944A1 (en) 2007-12-06
IL182494A (en) 2011-07-31
AU2005293881B2 (en) 2010-02-25
AU2005293881A1 (en) 2006-04-20
CN101039671B (zh) 2010-10-13
JP4980917B2 (ja) 2012-07-18
CN101039671A (zh) 2007-09-19
MX2007004297A (es) 2008-03-11
JP2008516901A (ja) 2008-05-22
NZ554469A (en) 2010-02-26
US7645759B2 (en) 2010-01-12
BRPI0515983A (pt) 2008-08-12
ES2299090T3 (es) 2008-05-16
HK1107263A1 (en) 2008-04-03
CA2583920A1 (en) 2006-04-20
SI1799214T1 (sl) 2008-06-30
EA200700584A1 (ru) 2007-10-26
ZA200703009B (en) 2008-08-27
EP1799214B1 (de) 2007-12-26
IL182494A0 (en) 2007-09-20
WO2006040004A1 (en) 2006-04-20
RS50563B (sr) 2010-05-07
ITMI20041963A1 (it) 2005-01-15

Similar Documents

Publication Publication Date Title
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
DE60307677D1 (de) Dispergierbare pharmazeutische zusammensetzungen
ATE475434T1 (de) Hämostatische sprays und zusammensetzungen
PL1861387T3 (pl) Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
IL183986A0 (en) Pharmaceutical compounds and compositions
DE602005001833D1 (de) Zusammensetzungen enthaltend Ecteinascidin und einen Disaccharide
IL182494A0 (en) Non-peptide bradykinin antagonists and pharmaceutical composition therefrom
DK1587478T3 (da) Farmaceutisk sammensætning
ZA200702216B (en) Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
DK2783682T3 (da) Farmaceutisk sammensætning omfattende pimobendan
ATE446091T1 (de) Basische nichtpeptid-bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus
IL221395A0 (en) Pharmaceutical compositions comprising alpha ketoamide derivatives and uses thereof
IL177073A (en) Hydroxy-6-Hydroyl-Pananthridine History and Containing Pharmaceuticals
IL181730A0 (en) Benzodiazinone derivatives and pharmaceutical compositions containing the same
PT1861387E (pt) Derivados de benzimidazol e composições farmacêuticas dos mesmos
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
DK1808446T3 (da) IL-18-receptor-antagonist og farmaceutisk sammensætning indeholdende antagonisten
IL178067A0 (en) Pharmaceutical dosage forms and compositions
AP1994A (en) An antimycobacterial pharmaceutical composition
IL177498A0 (en) Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
DK2474528T3 (da) Antineoplastiske forbindelser og farmaceutiske kompositioner deraf
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
DE602005005033D1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen
ATE439841T1 (de) Pharmazeutische zusammensetzungen mit zd6474

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1799214

Country of ref document: EP